Andrew Hendifar

ORCID: 0000-0002-2079-9177

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 22 papers. Top paper: “Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211)”.

Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211)

Journal of Clinical Oncology(2022)10.1200/jco.22.01013

N/A

4.9DataRank · unranked

297 citations

Noah Graham, Paul J. Catalano, Halla Nimeiri, George A. Fisher, Teri A. Longacre +14 more

Phase I trial of Bermekimab with nanoliposomal irinotecan and 5-fluorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma

Scientific Reports(2022)10.1038/s41598-022-19401-3

N/A

0.587DataRank · unranked

10 citations

Shant Thomassian, Sungjin Kim, Gillian Gresham, Natalie Moshayedi, Jason Ye +9 more

A prospective trial of elemental enteral feeding in patients with pancreatic cancer cachexia (PANCAX-1).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.4_suppl.726

N/A

0DataRank · unranked

2 citations

Gillian Gresham, Haesoo Kim, Michelle Guan, Jar-Yee Liu, Brian Minton +6 more

Feasibility and efficacy of enteral tube feeding on weight stability, lean body mass, and patient‐reported outcomes in pancreatic cancer cachexia

Journal of Cachexia Sarcopenia and Muscle(2021)10.1002/jcsm.12799

N/A

0DataRank · unranked

24 citations

Veronica Placencio-Hickok, Marie Lauzon, Tyra Nguyen, Haesoo Kim, Sejal Mehta +9 more

Dual Stromal Targeting Sensitizes Pancreatic Adenocarcinoma for Anti-Programmed Cell Death Protein 1 Therapy

Gastroenterology(2022)10.1053/j.gastro.2022.06.027

N/A

0DataRank · unranked

76 citations

Jianxin Wang, John Davelaar, Andrew Baker, Keyu Li, Nan Niu +17 more

Addressing unmet needs for people with cancer cachexia: recommendations from a multistakeholder workshop

Journal of Cachexia Sarcopenia and Muscle(2022)10.1002/jcsm.12910

N/A

0DataRank · unranked

34 citations

Richard F. Dunne, Kristen Santiago, Lisa Martin, Morris J. Birnbaum, Jeffrey Crawford +9 more

A randomized study of temozolomide or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors: Final analysis of efficacy and evaluation of MGMT (ECOG-ACRIN E2211).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.4004

N/A

0DataRank · unranked

21 citations

Noah Graham, Paul J. Catalano, Halla Nimeiri, George A. Fisher, Teri A. Longacre +15 more

Trial in progress: A randomized phase II study of pembrolizumab with or without defactinib, a focal adhesion kinase inhibitor, following chemotherapy as a neoadjuvant and adjuvant treatment for resectable pancreatic ductal adenocarcinoma (PDAC).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps4192

N/A

0DataRank · unranked

6 citations

Zachariah Brown, Sheila Linden, Christina Rodriguez, Omer H. Elmadbouh, Jonathan A. Pachter +9 more

Author Correction: Phase I trial of Bermekimab with nanoliposomal irinotecan and 5‑fuorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma

Scientific Reports(2022)10.1038/s41598-022-23619-6

N/A

0DataRank · unranked

1 citations

Shant Thomassian, Sungjin Kim, Gillian Gresham, Natalie Moshayedi, Jason Ye +9 more

Recent advances in the management of hepatocellular carcinoma

Clinical and Molecular Hepatology(2023)10.3350/cmh.2023.0125

N/A

0DataRank · unranked

138 citations

Jun Gong, Arsen Osipov, Steven A. Miles, Kambiz Kosari, Nicholas N. Nissen +4 more

COVID-19 Pandemic Impact on Diagnosis, Stage, and Treatment of Hepatocellular Carcinoma in the United States

Gastro Hep Advances(2023)10.1016/j.gastha.2023.11.011

N/A

0DataRank · unranked

6 citations

Yee Hui Yeo, Jeff Liang, Michael Luu, Walid S. Ayoub, Alexander Kuo +11 more

Multitasking dynamic contrast enhanced magnetic resonance imaging can accurately differentiate chronic pancreatitis from pancreatic ductal adenocarcinoma

Frontiers in Oncology(2023)10.3389/fonc.2022.1007134

N/A

0DataRank · unranked

10 citations

Srinivas Gaddam, Yibin Xie, Anthony Christodoulou, Chaowei Wu, Sen Ma +7 more

Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad096

N/A

0DataRank · unranked

9 citations

Thomas A. Hope, Emily B Bergsland, Lisa Bodei, David Bushnell, Jennifer A. Chan +63 more

Preliminary translational immune and stromal correlates in a randomized phase II trial of pembrolizumab with or without defactinib for resectable pancreatic ductal adenocarcinoma (PDAC).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.4024

N/A

0DataRank · unranked

5 citations

John Davelaar, Jessica Gai, Zachariah Brown, Abrahm Levi, Sheila Linden +15 more

The Molecular Twin artificial-intelligence platform integrates multi-omic data to predict outcomes for pancreatic adenocarcinoma patients

Nature Cancer(2024)10.1038/s43018-023-00697-7

N/A

0DataRank · unranked

87 citations

Ognjen Nikolic, Arkadiusz Gertych, Sarah J. Parker, Andrew Hendifar, Pranav Singh +9 more

Cancer-related cells and oncosomes in the liquid biopsy of pancreatic cancer patients undergoing surgery

npj Precision Oncology(2024)10.1038/s41698-024-00521-0

N/A

0DataRank · unranked

18 citations

Emmeline Lin, Nicholas N. Nissen, George Courcoubetis, Divya Suresh, Jeremy Mason +8 more

Keratin 17 modulates the immune topography of pancreatic cancer

Journal of Translational Medicine(2024)10.1186/s12967-024-05252-1

N/A

0DataRank · unranked

4 citations

Michael Horowitz, Mariana Torrente-Goncalves, Lucia Roa‐Peña, Cindy V. Leiton, Mahmudul Hasan +20 more

Neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma (PDAC) with germline DNA damage repair (DDR) mutations: A dual institution retrospective study.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.4164

N/A

0DataRank · unranked

1 citations

Marco Ventin, Giulia Cattaneo, Arya Shahrzad, Anser Abbas, Brent K. Larson +13 more

Clinical outcomes and molecular characteristics of lung-only and liver-only metastatic pancreatic cancer: results from a real-world evidence database

The Oncologist(2025)10.1093/oncolo/oyaf007

N/A

0DataRank · unranked

7 citations

Edik M. Blais, John Davelaar, Matthew Ebia, Angela Minasyan, Nima Nikravesh +13 more

Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial

The Lancet Oncology(2020)10.1016/s1470-2045(20)30074-7

N/A

0DataRank · unranked

546 citations

Edik M. Blais, Jonathan R. Brody, Emily E. Lyons, Patricia DeArbeloa, Andrew Hendifar +11 more

Enhancing management of pancreatic cancer: impact of a same day multidisciplinary clinic on access to guideline-directed care

HPB(2025)10.1016/j.hpb.2025.07.012

N/A

0DataRank · unranked

0 citations

Anser Abbas, Abrahm Levi, John Davelaar, Elissa Rosenberg, Katelyn M. Atkins +18 more

Multiparametric Mapping Magnetic Resonance Imaging of Pancreatic Disease

Frontiers in Physiology(2020)10.3389/fphys.2020.00008

N/A

0DataRank · unranked

41 citations

Srinivas Gaddam, Nan Wang, Yibin Xie, Zixin Deng, Zhengwei Zhou +10 more